The company filed this filing as consent from Altus Group regarding their role in the valuation process. The stock closed at $20.63 per share Monday, a gain of 0.05%.
The company filed this filing as consent from Altus Group regarding their role in the valuation process. The stock closed at $20.63 per share Monday, a gain of 0.05%.